Prim. Univ. Prof. Dr. Thomas Gruenberger

Pastpräsident

1. Chirurgische Abteilung
KA Rudolfstiftung

Juchgasse 25
1030 Wien

Tel: +43-1-711 65 - 4107
Fax: +43-1-711 65 - 4109
Email: tgruenberger@icloud.com


CURRICULUM VITAE

Name Thomas Gruenberger
Born: 23. Feb. 1964
Parents: Viktor Gruenberger, Professor of Gynecology and Obstetrics
Martha Gruenberger, housewife
Married: February 2005: to Birgit (maiden name: Schuell), M.D.
Three children (Dionne born May 1997, Lukas Pippin December 2008, Nikolaus Laurin June 2011)
Adress: University of Vienna, Department of General Surgery,
Hepatobiliary Service
Waehringer Guertel 18-20
1090 Vienna, Austria
Tel: +43-1-40400-5621
Fax: +43-1-40400-5641
 

SCHOOL CAREER:

1970-1974: Primary school in Vienna (VS Albertus Magnus)
1974-1982: High school (Akademisches Gymnasium) in Vienna, final exams passed on 31 May 1982
 

UNIVERSITY CAREER:

1982-1991: Medical studies at University of Vienna, Vienna Austria
Diploma granted (M.D.): 13 March 1991
04.09.1991: Military service in the military hospital of Vienna (Heeresspital Wien)
 

POSTGRADUATE QUALIFICATION:

31.01.1998: State registration as fully trained specialist in General Surgery
11.06.2002: Associate Professor of Surgery, University of Vienna
 

POSTGRADUATE APPOINTMENTS:

10.91-04.97 Registrar in Surgery, University of Vienna
04.97-03.99 Senior Registrar/Consultant, University of Vienna & Surgical Department KH Baden (district hospital, Austria)
04.99–01.2000 Liver unit Prof. DL. Morris, St. George Hospital, UNSW, Sydney; Research Fellow
02.00–03.2001 Department of Surgery, St. George Hospital, University of New South Wales, Sydney, Australia;
Senior Lecturer in Surgery; Deputy Chief of the liver unit (Chief: Prof DL Morris)
05.2001- current Consultant, Department of General Surgery;
Head Hepatobiliary Service, Department of General Surgery, University of Vienna
06.2003 06.2003 Head HPB-branch Austrian Society of Surgical Oncology
10.2005 Secretary-General Austrian Society of Surgical Oncology
04.2006 Member of the Pan-European Consensus Conference for the Treatment of Colorectal Cancer Liver Metastases
06.2007 Member of the colorectal task Force of the ABCSG
09.2008 Executive Board member, European Society of Surgical Oncology
10.2008 President elect, Austrian Society of Surgical Oncology
10.2009 Associate Editor of the HPB Section of the European Journal of Surgical Oncology
05.2009 Vice-Editor in Chief, European Journal for Digestive Oncology
03.2010 Head of the Liver Task Force of the Austrian Breast and Colorectal cancer Study Group (ABCSG)

 

EDITORIAL BOARD OF PEER REVIEWED JOURNALS:

European Surgery (Acta Chirurgica Austriaca) 05.2004
Journal Gastroenterology and Hepatology 02.2004
European Journal of Surgical Oncology 01.2009
Digestive Oncology Journal 01.2009

Reviewer for peer reviewed scientific journals:

European Surgery 05.2004
Journal Gastroenterology and Hepatology 02.2004
European Journal of Surgical Oncology 12.2006
British Journal of Surgery 09.2007
Journal of Clinical Oncology 04.2008
Clinical Colorectal Cancer 05.2008
Reviews on Recent Clinical Trials 07.2008
Magazine of European Medical Oncology 01.2009
Annals of Surgical Oncology 04.2009
Annals of Surgery 10.2009

MEMBERSHIP OF LEARNED SOCIETIES:

Austrian Society for Surgery (ÖGC, since 1992)
German Society for Surgery (DGC, since 1997)
European Society of Transplantation (ESOT, since 1995)
Austrian Society of Transplantation (ASOT, since 1992)
Working Party for Minimally Invasiv Surgery (AMIC) of the ÖGC (since 1994)
Austrian Society for Gastroenterology and Hepatology (since 1995)
Working party for Coloproctology of the ÖGC (since 1995)
European Digestive Surgery (CICD and EDS, since 1998)
Transplantation Society of Australia and New Zealand (since 2000)
International Hepato Pancreato Biliary Association (since 2000)
The Transplantation Society (since 2000)
European Organisation of Research and Treatment of Cancer, EORTC (since 2002)
European Society of Surgical Oncology (since 2003)
European Society of Medical Oncology (since 2003)
Austrian Society of Haematology and Oncology (since 2004)
American Society of Clinical Oncology (since 2004)
Faculty of the Gastro Intestinal Cancer Society (since 2005)

ADVISORY ROLE:

  • Roche, since 01/2009
  • Pfizer, since 06/2009

POSTGRADUATE COURSES:

  • European College of Transplantation (Hesperis; Rom1992; Munich 1993)
  • Austrian Clinical Oncology symposium: breast cancer (Salzburg, Austria 1993)
  • Austrian Clinical Oncology symposium: colon cancer (Poertschach, Austria 1995)
  • Workshop liver tumors (Mainz, Germany 1996)
  • Update Internal medicine (Vienna, Austria 1997)
  • Austrian Clinical Oncology symposium: rectal cancer (Villach, Austria 1997)
  • International Workshop on hepatic Cryosurgery (Neijmegen, NL 1998)
  • Advanced course for vascular surgeons (Zermatt, CH 1998)
  • Central European Transplant Workshop (Prag, CZ 1998)
  • Austrian Clinical Oncology symposium: liver cancer (Poertschach, Austria 1998)
  • Laparoscopic Nephrectomy Workshop (Sydney, Australia 2000)
  • Current concepts in Liver Surgery at Hospital Henri Mondor, Prof Daniel Cherqui and Hospital Paul Brousse, Prof Henri Bismuth (Paris, France 2001)
  • Workshop Radiofrequency Ablation techniques (Milan, Italy 2002)
  • CoMITT (Congress of minimal invasive tumor therapy) including Workshop percutanous RFA (Munich, Germany 2003)
  • Workshop Abdominal MRT Imaging (Pöchlarn, Austria 2003)
  • Workshop interventional treatment strategies of HCC (Vienna, Austria 2003)
  • Masterclass in laparoscopic colorectal surgery (Paris, France 2003)
  • New Technologies in Liver Surgery (Strassbourg, France 2004)
  • Gastrointestinal neuroendocrine tumors, actual treatment strategies (Vienna, Austria 2005)
  • Angiogenesis: a key target in Oncology (Barcelona, Spain 2008)

PhD Thesis Advisor and Supervisor:

  • Doz. Dr. Harald Puhalla
  • Doz. Dr. Birgit Gruenberger
  • Doz. Dr. Dietmar Tamandl

RESEARCH GRANTS:

  • Novartis Research Grant – 1996: study to evaluate supplemental enteral nutrition in clinical liver resection; 100.000,- ÖS
  • Viennese Mayor Council Grant – 1998: study to evaluate glycine supplementation in preventing nephrotoxicity after liver transplantation; 175.000,- ÖS
  • Viennese National Bank Grant – 1998: study evaluating early postoperative feeding and outcome in ICU patients after major intracranial bleeding; 130.000,- ÖS
  • Novartis Research Grant – 1999: study to investigate immunological changes and outcome in colorectal cancer patients perioperatively fed with an immunenhancing diet; 330.000 ÖS
  • Viennese Major Council Research Grant – 2003: liver metastases after colorectal cancer; influence of specific genetic alterations on prognosis and response to chemotherapy; 17.000,- €
  • Viennese Major Council Research Grant – 2008: influence of Bevacizumab upon systemic angiogenesis capacity; 30.000,- €

Competitive Research Grants through Participation in international Studies:

  • Metastatic Colorectal Cancer: app. 150.000,- €
  • Hepatocellular Cancer: 35.000,- €

CONGRESS ORGANISATION AND MANAGEMENT:

  • Annual Meeting of the Austrian Society of Surgical Oncology; President, September 2004, Salzburg Austria
  • Annual Live OP-Workshop, Multidisciplinary Treatment of Liver Tumours; President, April 2006, General Hospital Vienna, Austria
  • 1st Surgical Advisory Board Meeting on the treatment of colorectal liver metastases; President, March 2008, Vienna Austria
  • Work-Shop “DeLiver Excellence”, current treatment algorithm in mCRC; September 2009; Vienna, Austria
  • Work-Shop “DeLiver Excellence”, current treatment algorithm in mCRC; November 2009; Loipersdorf, Austria

MEMBER OF CONSENSUS CONFERENCES:

  • European Consensus of treating colorectal cancer liver metastases (2006 onwards, several international locations)
  • Merck International Consensus on treating mCRC (Vienna 2007)
  • Merck Austrian Consensus on treating mCRC (Vienna 2007)
  • Merck European Advisory network of treating mCRC (Athens 2007)
  • Bayer Austrian Consensus on future prospective of Sorafinib in the treatment of HCC (Vienna 2008)
  • Merck Surgical Consensus on treating colorectal cancer liver metastases (Vienna 2008)

SCIENTIFIC REFERENCES:

The reference list comprises over 160 citations in national and international journals and over 200 citations of lecturing and presentations at international conferences.

The articles are divided into:

•) 93 Original articles: 48 as leading or senior author 45 as Co-author
•) 114 referenced lectures and cited abstract
•) 10 book contributions, 1 book Editing
•) 0ver 200 Congress reports and invited Lectures

Impact Factor total: 312,786
Impact Factor first or senior author: 186,481